Antiretroviral therapy during infancy: essential intervention for resource-limited settings

Brian S Eley1

  • 1Paediatric Infectious Diseases Unit, Red Cross Children's Hospital, School of Child and Adolescent Health, University of Cape Town, Rondebosch, Cape Town, South Africa. brian.eley@uct.ac.za

Insights

Early treatment with highly active antiretroviral therapy (HAART) in HIV-infected African infants shows favorable short-term outcomes and high adherence rates. This supports current guidelines recommending prompt HAART initiation for all HIV-infected infants.

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Global health

Background:

  • Limited data exists on highly active antiretroviral therapy (HAART) outcomes in infants from low- and middle-income countries.
  • Untreated HIV-infected infants under two years old represent a particularly vulnerable population.
  • This study evaluates a randomized trial of immediate versus deferred HAART in 63 HIV-infected infants in a resource-poor setting.

Discussion:

  • The study's findings align with recent global treatment guidelines advocating for early HAART initiation in all HIV-infected infants, regardless of clinical or immunological status.
  • The favorable short-term outcomes and high adherence rates observed in both immediate and deferred HAART groups are critical considerations for resource-limited settings.
  • The implications of these findings for public health policy and clinical practice in managing pediatric HIV in developing nations are significant.

Key Insights:

  • Immediate HAART initiation in HIV-infected African infants demonstrated favorable short-term virological suppression.
  • Deferred HAART initiation also yielded positive short-term outcomes, indicating potential flexibility in treatment timing.
  • High adherence rates were observed in both treatment arms, suggesting feasibility of HAART management in resource-poor settings.

Outlook:

  • Further research is needed to assess the long-term efficacy and safety of early HAART in this population.
  • The findings support the integration of early infant diagnosis and prompt treatment into HIV/AIDS management programs in resource-limited settings.
  • Continued monitoring and evaluation are essential to optimize pediatric HIV care strategies globally.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...